Sun Pharma buying Organon $11.75B, largest Indian pharma acquisition
NewsBytes | April 28, 2026 7:42 PM CST
Sun Pharma expects manageable debt
After the buyout, Sun Pharma expects its debt to stay manageable, thanks to strong cash flow and over $350 million in planned cost savings.
The company also plans to use Organon's worldwide network to push its specialty medicines further, aiming for bigger global reach and stronger earnings.
READ NEXT
-
Lemon rice will double the fun of food! South Indian taste will be ready in minutes
-
Gulkand Thandai Recipe: Make cold Gulkand Thandai in 10 minutes, you will get instant relief in summer drink
-
MI vs SRH, IPL 2026: Rickelton smashes maiden IPL century
-
Draymond Green drops a hint about LeBron James retirement
-
Franz Wagner Has Calf Strain, Unlikely To Play Game 5
